Non Invasive Evaluation of Fluid Responsiveness in Septic Patient
NCT ID: NCT05310942
Last Updated: 2022-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2021-12-17
2023-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Echocardiography Guided Fluid Resuscitation in Critically Ill Patients.
NCT03296319
Cardiometry in Hypotensive and Pumonary Congestion
NCT06730087
Volume Responsiveness By Ultrasound Of Carotid Blood Flow In Patients With Cardiogenic Shock
NCT05271227
Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status
NCT02907931
The Impact of Point-of-Care Ultrasound
NCT03276364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will be conducted according to CONSORT 2010 statement. Enrolment of eligible patients will occur within 8 h of meeting the criteria for septic shock. All patients will be randomized using the computer-generated software of randomization and sealed closed envelopes to allocate them to one of two groups (30 patients each). Routine measurements and investigations will be taken at admission to intensive care unit; history, vital signs, routine laboratory investigation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
The fluid management of patients in this group will be assessed by IVC collapsibility index (IVC CI) calculated by ultrasound through maximum IVC diameter - minimum IVC diameter divided by maximum diameter then multiplied by 100. If it is less than 50% means that the patient is volume non- depleted while if it is more than 50% means the reverse.
No interventions assigned to this group
B
All patients in this group with sepsis will be evaluated by the electrical cardiometry monitor.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18-65 years old of both genders.
3. Fulfilment criteria of sepsis as defined according to the standard Surviving Sepsis Campaign criteria using the Sequential (sepsis-related) Organ Failure Assessment (SOFA) score (SOFA score ≥ 2 indicated organ dysfunction).
4. Patients within 8 h of meeting the criteria for septic shock.
Exclusion Criteria
2. Age below 18 and above 65 years old.
3. acute coronary syndrome
4. major cardiac dysrhythmia,
5. valvular or congenital heart disease
6. Massive bilateral pleural effusion
7. Severe anaemia
8. End-stage kidney disease (ESKD) patients with Creatinine clearance (CrCl) \<50ml/min.
9. Child B and Child C hepatic patients
10. impaired systolic function according to the ejection fraction (EF) (EF \< 40% indicated impaired systolic function)
11. Severe ARDS (acute respiratory distress syndrome).
12. Tense ascites
13. Mechanical ventilation.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ebtehal Shaheen
assisstant lecturer at faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Banhā, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MD17-12-2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.